Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor.
Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor.
复制标题
DOI:
10.3390/ijms23031182
复制
发表时间:
2022-01-21
影响因子:
5.6
通讯作者:
Chang SL
中科院分区:
文献类型:
--
作者:
Caradonna A;Patel T;Toleska M;Alabed S;Chang SL
Alzheimer’s disease (AD) is characterized by the deposition of amyloid-beta (Aβ) plaques from improper amyloid-beta precursor protein (APP) cleavage. Following studies of inflammation caused by coronavirus-2019 (COVID-19) infection, this study investigated the impact of COVID-19 on APP expression. A meta-analysis was conducted utilizing QIAGEN Ingenuity Pathway Analysis (IPA) to examine the link between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and the modulation of APP expression upon virus binding the Angiotensin-converting enzyme-2 (ACE2) receptor. A Core Analysis was run on the infection by severe acute respiratory syndrome (SARS) coronavirus node, which included molecules affected by SARS-CoV-2, revealing its upstream regulators. Intermediary molecules were found between the upstream regulators and ACE2 and between ACE2 and APP. Activation of the upstream regulators downregulated the expression of ACE2 with a Z-score of −1.719 (p-value = 0.086) and upregulated APP with a Z-score of 1.898 (p-value = 0.058), showing a less than 10% chance of the results occurring by chance and pointing to an inverse relationship between ACE2 and APP expression. The neuroinflammation signaling pathway was the fifth top canonical pathway involved in APP upregulation. The study results suggest that ACE2 could be downregulated by SARS-CoV-2, resulting in APP upregulation, and potentially exacerbating the onset and progression of AD.
登录
查看更多内容
DOI:
10.1007/s10096-020-04138-6
发表时间:
2021-05
期刊:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
影响因子:
--
作者:
Beyerstedt S;Casaro EB;Rangel ÉB
通讯作者:
Rangel ÉB
DOI:
10.1186/s13195-020-00744-w
发表时间:
2020-12-30
期刊:
Alzheimer's research & therapy
影响因子:
--
作者:
Miners S;Kehoe PG;Love S
通讯作者:
Love S
DOI:
10.1186/s13195-016-0217-7
发表时间:
2016-11-25
期刊:
Alzheimer's research & therapy
影响因子:
--
作者:
Kehoe PG;Wong S;Al Mulhim N;Palmer LE;Miners JS
通讯作者:
Miners JS
DOI:
10.3390/healthcare8030286
发表时间:
2020-08-21
期刊:
Healthcare (Basel, Switzerland)
影响因子:
--
作者:
Abate G;Memo M;Uberti D
通讯作者:
Uberti D
影响因子:
5.4
作者:
Glowacka, Ilona;Bertram, Stephanie;Poehlmann, Stefan
通讯作者:
Poehlmann, Stefan